drugset / Trial / NCT02244567

Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome Women

NCT02244567

Phase 1 Unknown 100 enrolled Beni-Suef University Cairo University · collab
RandomizedSingle-groupSingle-blindTreatment

Summary

High ucOC may favor insulin release in lean hyperandrogenic women to compensate for impaired insulin sensitivity. Meformin is an insulin sensitizing agent will be given for these women trying to interfere with the pathophysiology of PCOS in these women as followed up by serum UC-OC levels.

Timeline

Start
2014-09
Primary completion
2021-06
Completion
2021-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 850 mg Oral